Trial Profile
International Active Surveillance Study of Medication Used for the Treatment of Endometriosis: Visanne Post-approval Observational Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2021
Price :
$35
*
At a glance
- Drugs Dienogest (Primary) ; Danazol; Hormonal contraceptives; Hormones; Progesterone congeners
- Indications Endometriosis
- Focus Adverse reactions
- Acronyms VIPOS
- 27 Jul 2020 Status changed from active, no longer recruiting to completed.
- 16 Apr 2020 Results of long-term follow-up analysis of clinical outcomes were published in the Advances in Therapy
- 10 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Nov 2018.